PLG and COVID-19: Thus, it has been proposed that nebuliser plasminogen activators, including pre-existing drugs, such as Tenecteplase, a modified recombinant tPA molecule, may be used as a treatment for COVID-19 patients, by facilitating fibrin degradation [220].